Infantile epileptic spasm syndrome: predictors of short- and long-term outcomes. [PDF]
Al-Omari MA +4 more
europepmc +1 more source
Network analysis of antiseizure medication use, efficacy, and safety in epilepsy: A retrospective cohort study in a tertiary care center. [PDF]
Morales-Morales MA +10 more
europepmc +1 more source
TUBA1A-related tubulinopathy associated with the infantile epileptic spasms syndrome and atypical absence seizures. [PDF]
Ng AC, Scantlebury MH.
europepmc +1 more source
One Size Does Not Fit All: Novel Individualized Use of Dexamethasone in Infantile Epileptic Spasms Syndrome. [PDF]
Kabak E +3 more
europepmc +1 more source
Subacute sclerosing panencephalitis in a child six years after measles infection. [PDF]
Le Feur L +6 more
europepmc +1 more source
Epidemiology of Epileptic Spasm and Affecting Factors on One-Year Prognosis: A Study in Tabriz Children's Hospital. [PDF]
Sadeghvand S +8 more
europepmc +1 more source
DNA methylation of antiseizure medication metabolism genes and pharmacokinetic changes in adult epilepsy patients treated with the modified Atkins diet. [PDF]
Gervin K +6 more
europepmc +1 more source
Real-world disproportionality analysis of sleep disturbances associated with antiseizure medications in epilepsy: a pharmacovigilance study. [PDF]
Gou C, Yang M, Zhao Q, Han Y.
europepmc +1 more source
Pharmacovigilance study of drug-induced eye movement disorder based on FDA adverse event reports from 2004 to 2024. [PDF]
Hong SY +5 more
europepmc +1 more source
Mechanistic strategies for secondary prevention of developmental and epileptic encephalopathy in children with tuberous sclerosis complex. [PDF]
Specchio N +4 more
europepmc +1 more source

